Kelatorphan

Kelatorphan is a potent inhibitor of multiple neuropeptidases. It was first isolated from the skin of the African clawed frog and has been found to inhibit a broad range of enzymes involved in the degradation of neuropeptides. This makes it a useful tool for studying the role of these peptides in the body.

Structure and Function

Kelatorphan is a linear polypeptide consisting of 19 amino acid residues. It has a unique structure that allows it to bind to and inhibit a wide range of neuropeptidase enzymes. These enzymes are responsible for breaking down neuropeptides, which are small proteins that act as neurotransmitters in the nervous system. By inhibiting these enzymes, kelatorphan can increase the levels of certain neuropeptides in the body, which can have various effects on physiological processes.

Medical Applications

Due to its ability to inhibit a broad range of neuropeptidases, kelatorphan has potential applications in the treatment of various medical conditions. For example, it has been studied for its potential use in the treatment of pain, inflammation, and certain neurological disorders. However, more research is needed to fully understand the potential benefits and risks of using kelatorphan in a medical context.

Research and Development

Research into the potential medical applications of kelatorphan is ongoing. Initial studies have shown promising results, but more work is needed to confirm these findings and to determine the best ways to administer the drug and monitor its effects. As with any new drug, it will be important to conduct rigorous clinical trials to ensure that kelatorphan is safe and effective before it can be approved for use in humans.

See Also

• Neuropeptide
• Neurotransmitter
• African clawed frog
• Clinical trial

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia